Description

UCB innovates and delivers solutions that make real improvements for people living with severe diseases. We partner with and listen to patients, caregivers and stakeholders across the healthcare system to identify promising innovations that create valuable health solutions.

Bounties

This is a responsible disclosure program without bounties.

Rules of engagement
Required
Not applicable
max. 1 request /sec
X-Intigriti: <username>

By participating in this program, you agree to:

  • Respect the Community Code of Conduct
  • Respect the Intigriti Terms and Conditions
  • Respect the scope of the program
  • Not discuss or disclose vulnerability information without prior written consent (including PoC's on YouTube and Vimeo)

Check our fix
We offer up to €50 bonus to verify a resolved issue for us (when requested).
This remains at the discretion of UCB Biopharma SRL to award.

Country sanctions warning
Researchers that are residents, nationals or located in countries subject to economic sanctions as administered by the US Office of Foreign Assets Control (OFAC) are not allowed to participate in this program and will not receive any Bounty payments. These countries may include (but not be limited to): Cuba, Iran, North Korea, Syria and the following regions of Ukraine: Crimea, Donetsk and Luhansk.

Domains
No bounty
URL

UCB's Global Corporate Website

In scope

Doomsday scenarios

  • We are especially looking for vulnerabilities that could lead to:
    • Compromise of our IT systems
    • Risk to patients / patient data

Avoid impact to our systems

  • Do not automatically submit forms
  • Be careful with your tests and avoid any impact to patients and/or services.
  • If you suspect that your tests caused any damage to the systems, please report the first steps and request permission to continue.
  • Please do not scan our systems automatically. Please limit all automated requests to 1 requests per second.
  • Do not modify any information or code

Do not access confidential info

  • It is prohibited to access any confidential information. If you accidentally access any of these, please stop and report the finding immediately.
Out of scope

Only assets listed in the domain section are in-scope.

Application

  • Missing captcha
  • Wordpress usernames disclosure
  • Pre-Auth Account takeover/OAuth squatting
  • Self-XSS that can't be used to exploit other users
  • Verbose messages/files/directory listings without disclosing any sensitive information
  • CORS misconfiguration on non-sensitive endpoints
  • Missing cookie flags
  • Missing security headers
  • Cross-site Request Forgery with no or low impact
  • Presence of autocomplete attribute on web forms
  • Reverse tabnabbing
  • Bypassing rate-limits or the non-existence of rate-limits.
  • Best practices violations (password complexity, expiration, re-use, etc.)
  • Clickjacking without proven impact/unrealistic user interaction
  • CSV Injection
  • Sessions not being invalidated (logout, enabling 2FA, etc.)
  • Tokens leaked to third parties
  • Anything related to email spoofing, SPF, DMARC or DKIM
  • Content injection without being able to modify the HTML
  • Username/email enumeration
  • Email bombing
  • HTTP Request smuggling without any proven impact
  • Homograph attacks
  • XMLRPC enabled
  • Banner grabbing/Version disclosure
  • Not stripping metadata of files
  • Same-site scripting
  • Subdomain takeover without taking over the subdomain
  • Arbitrary file upload without proof of the existence of the uploaded file
  • Blind SSRF without proven business impact (pingbacks aren't sufficient)
  • Disclosed/misconfigured Google Maps API keys
  • Host header injection without proven business impact

General

  • In case that a reported vulnerability was already known to the company from their own tests, it will be flagged as a duplicate
  • Theoretical security issues with no realistic exploit scenario(s) or attack surfaces, or issues that would require complex end user interactions to be exploited
  • Spam, social engineering and physical intrusion
  • DoS/DDoS attacks or brute force attacks
  • Vulnerabilities that only work on software that no longer receive security updates
  • Attacks requiring physical access to a victim's computer/device, man in the middle or compromised user accounts
  • Recently discovered zero-day vulnerabilities found in in-scope assets within 14 days after the public release of a patch or mitigation may be reported, but are usually not eligible for a bounty
  • Reports that state that software is out of date/vulnerable without a proof-of-concept
Severity assessment

This program follows Intigriti's triage standards

FAQ

Where can we get credentials for the app?

You can self-register on the application but please don’t forget to use your @intigriti.me address.

All aboard!
Please log in or sign up on the platform

For obvious reasons we can only allow submissions or applications for our program with a valid Intigriti account.

It will only take 2 minutes to create a new one or even less to log in with an existing account, so don't hesitate and let's get started. We would be thrilled to have you as part of our community.

Program specifics
No collaboration
Activity
4/2
UCB Biopharma SRL
changed the severity assessment
8/7
UCB Biopharma SRL
changed the rules of engagement
8/6
UCB Biopharma SRL
unsuspended the program
4/26
UCB Biopharma SRL
suspended the program
3/22
UCB Biopharma SRL
changed the faq
3/19
UCB Biopharma SRL
unsuspended the program
2/23
UCB Biopharma SRL
changed the in scope
2/21
UCB Biopharma SRL
suspended the program
2/21
UCB Biopharma SRL
unsuspended the program
2/21
UCB Biopharma SRL
suspended the program